Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Indocyanine Green Fluorescence Imaging, Sentinel Lymph Node Mapping in Patients With Vulvar Cancer: Peritumoral Injection Dosage and Waiting Times in Our Experience

NCT04663412 is registered in ClinicalTrials.gov with Azienda Ospedaliera per l'Emergenza Canizzaro as lead sponsor.

NCT NCT04663412
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04663412 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Indocyanine Green Fluorescence Imaging, Sentinel Lymph Node Mapping in Patients With Vulvar Cancer: Peritumoral Injection Dosage and Waiting Times in Our Experience
Lead sponsor
Azienda Ospedaliera per l'Emergenza Canizzaro
Phase
Not applicable
Overall status
Unknown status
Start date
July 9, 2020
Completion date
July 20, 2023
Enrollment
2 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vulvar cancer